Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 130

Sort by

Sort Order Select

Journal Articles

How I treat patients with hereditary antithrombin deficiency

Ingrid Pabinger, Johannes Thaler

Blood (2019) 134 (26): 2346–2353.

https://doi.org/10.1182/blood.2019002927

Published: 2019

Journal Articles

A Rare Presentation of Acute Immune Thrombocytopenia, Refractory to First Line Therapy, Despite Euthyroid State

Emily Molina, DO, MSPH, Gursharon Sanghera, MD, Patrick Hanley, MD, Rafat Ahmed, MD

Blood (2019) 134 (Supplement_1): 4900.

https://doi.org/10.1182/blood-2019-126200

Published: 2019

Journal Articles

Thrombotic Outcomes Following Hormonal Treatment of Heavy Menstrual Bleeding in Pediatric Patients Taking Anticoagulation

Michael H. White, MD, Gary Woods, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 2179.

https://doi.org/10.1182/blood-2019-130100

Published: 2019

Journal Articles

Catheter Directed Thrombolytic Therapy for Pediatric Cerebral Sinus Vein Thrombosis

Marcela Torres, MD, Tyler Hamby, PhD, Sarah Philip, MDcal Student, Jo Ann Tilley, DNP, APRN, CPNP

Blood (2019) 134 (Supplement_1): 3666.

https://doi.org/10.1182/blood-2019-132082

Published: 2019

Journal Articles

Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database

Jonathan C. Roberts, Lynn M Malec, MD, Imrran Halari, Sarah Hale, Abiola Oladapo, Robert Sidonio

Blood (2019) 134 (Supplement_1): 2117.

https://doi.org/10.1182/blood-2019-122164

Published: 2019

Journal Articles

Cerebral Venous Thrombosis Case Series at a Tertiary Care Hospital: Exploring Treatment Safety and Efficacy of Direct Oral Anticoagulants

Mohammed Abdullah Alsheef, MD, Mukhtar Alomar, PharmD, Abdul Rehman Z. Zaidi, MBBS, Ghaydaa Juma Kullab, MD, Mohammed AlHazzaa, MD, Asaad Bafaraj, MD, Abdullah Badahman, MD

Blood (2019) 134 (Supplement_1): 3658.

https://doi.org/10.1182/blood-2019-128406

Published: 2019

Journal Articles

A Pilot Study of an Oral Anticoagulant, Apixaban, in Secondary Prophylaxis of Venous Thromboembolism (VTE) in Children and Adolescents

Ashley Pinchinat, MD, Neida Otero, Harshini Mahanti, BS, MSCR, Erin Morris, RN, BSN, Adele Brudnicki, MD, Deborah Friedman, MD, Simon Li, MD, Oya Levendoglu-Tugal, MD, Mitchell S Cairo, MD

Blood (2019) 134 (Supplement_1): 2443.

https://doi.org/10.1182/blood-2019-130468

Published: 2019

Journal Articles

Hydroxyurea Exposure throughout Pregnancy in Patients with Sickle-Cell Disease : 4 Case Reports from European Non-Interventional, Multicentric, Prospective Escort-HU Study

Justine Gellen-Dautremer, MD, Sylvain Le Jeune, MD, Marie-Catherine Receveur, MD, Elena Foïs, MD

Blood (2019) 134 (Supplement_1): 1027.

https://doi.org/10.1182/blood-2019-126529

Published: 2019

Journal Articles

Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital

Lana A Castellucci, MD, Philip Chiang

Blood (2018) 132 (Supplement 1): 2532.

https://doi.org/10.1182/blood-2018-99-118369

Published: 2018

Journal Articles

Who Are the Type 2 Von Willebrand Disease Patients? Results from Interim Analysis of the French HRQoL Study: Wish-Qol .

Annie Borel-Derlon, MD PhD, Jenny Goudemand, MD PhD, Dominique Desprez, MD, Céline Falaise, Fabienne Genre Volot, MD, Laurent Ardillon, MD, Brigitte Pan-Petesch, MD, Catherine Chatelanaz, Catherine Doriat-Robin, Agnès Veyradier, Sr., MD PhD, Sylvia Von Mackensen

Blood (2018) 132 (Supplement 1): 2468.

https://doi.org/10.1182/blood-2018-99-113289

Published: 2018

Journal Articles

High Incidence and Recurrence Rate of Venous Thromboembolic Events in Patients with Sickle Cell Disease

Bart J. Biemond, MD PhD, Ewout R. Egner, MD, Erfan Nur, MD PhD, Charlotte F.J. Van Tuijn, MPH, PhD

Blood (2018) 132 (Supplement 1): 2381.

https://doi.org/10.1182/blood-2018-99-119343

Published: 2018

Journal Articles

Successful Management of Pregnancy with Severe Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor

Sajida Kazi, MRCP, FRCPATH, Ann Kinga Malinowski, MD MSc, FRCSC, Clare Whitehead, Kevin H. M. Kuo, MDMSc, FRCPC, Lynda Harrington, Nancy Watts, Chen Wang, MD PhD FRCPC, Nadine Shehata, MD FRCPC, MSc

Blood (2018) 132 (Supplement 1): 5077.

https://doi.org/10.1182/blood-2018-99-114949

Published: 2018

Journal Articles

Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay

Madeline Waldron, PharmD, Caitlin Siebenaller, PharmD, Marc Earl, PharmD, Xuefei Jia, MS, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Barb Tripp, CNS, Brian P. Hobbs, PhD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD MPH

Blood (2018) 132 (Supplement 1): 4806.

https://doi.org/10.1182/blood-2018-99-115257

Published: 2018

Journal Articles

Lipid-Mediated Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample

Pauline van Paridon, BSc, Marina Panova-Noeva, Rene van Oerle, Andreas Schulz, Jürgen Prochaska, Natalie Arnold, Irene Schmidtmann, Manfred Beutel, Norbert Pfeiffer, Thomas Münzel, Karl J. Lackner, Tilman M. Hackeng, PhD, Hugo ten Cate, MD PhD, Philipp Wild, Henri M.H. Spronk, PhD

Blood (2018) 132 (Supplement 1): 1169.

https://doi.org/10.1182/blood-2018-99-116932

Published: 2018

Journal Articles

Post Transplant Prophylaxis with High Dose Valacyclovir through Day 100 Versus Day of Post Transplant Hospital Discharge Decreases Cytomegalovirus Reactivation in Adult Umbilical Cord Blood Transplant Recipients

Prashant Sharma, MD, Jennifer MacDonald, Jeff Kaiser, Jennifer Tobin, Matthew Miller, Maheen Abidi, MD, Esther Benamu, MD, Enkhtsetseg Purev, MD PhD, Bradley M. Haverkos, MD MPH, MS, Jonathan A Gutman, MD

Blood (2018) 132 (Supplement 1): 4659.

https://doi.org/10.1182/blood-2018-99-110211

Published: 2018

Journal Articles

Levels of Protein S and Risk of Thromboembolism

Samip R Master, MD, John Hedgepeth, McLarty Jerry, Richard Preston Mansour, MD

Blood (2017) 130 (Supplement 1): 4899.

https://doi.org/10.1182/blood.V130.Suppl_1.4899.4899

Published: 2017

Journal Articles

Validation of the Peds Clot Clinical Decision Rule [PCDR] in Hospital-Acquired Venous Thromboembolism

Rachael Schultz, BA, Soyang Kwon, PhD, Anjali Sharathkumar, MBBS, MDMS, Rukhmi Bhat, MDMS

Blood (2017) 130 (Supplement 1): 3709.

https://doi.org/10.1182/blood.V130.Suppl_1.3709.3709

Published: 2017

Journal Articles

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Mahsen AlSaleh, MD, Tarek Owaidah, MD, Hazzaa Alzahrani, MD, Tahani Bin Ali, MD, Huda ElFaraidi, MD, Mahmoud Abu Riash, RN, Zikra Alkhayal, MD, AbdulKareem Al Momen, MD, Viqaruddin Mohammed, MSc, CCRP, Azzah AlZahrani, MD

Blood (2017) 130 (Supplement 1): 5587.

https://doi.org/10.1182/blood.V130.Suppl_1.5587.5587

Published: 2017

Journal Articles

Self-Reported Reproductive Health Experiences in Women with Von Willebrand Disease: A Qualitative Interview-Based Study

Ariela L. Marshall, MD, Harika Dasari, MBBS, Nathaniel D Warner, Diane E. Grill, Aneel A. Ashrani, MD MS, William L. Nichols, Jr., MD, Rajiv K. Pruthi, MD

Blood (2017) 130 (Supplement 1): 5588.

https://doi.org/10.1182/blood.V130.Suppl_1.5588.5588

Published: 2017

Journal Articles

Epidemiology and Long-Term Outcomes of Estrogen/Progesterone Associated Distal Deep-Vein Thrombosis

Jean-Philippe Galanaud, MD PhD, marie Antoinette Sevestre, MD PhD, Gilles Pernod, MD PhD, Genty Celine, msc, Susan Kahn, MD, Isabelle Quere, MD PhD, jean-Luc Bosson, MD PhD

Blood (2017) 130 (Supplement 1): 1100.

https://doi.org/10.1182/blood.V130.Suppl_1.1100.1100

Published: 2017

NARROW

How I treat patients with hereditary antithrombin deficiency

A Rare Presentation of Acute Immune Thrombocytopenia, Refractory to First Line Therapy, Despite Euthyroid State

Thrombotic Outcomes Following Hormonal Treatment of Heavy Menstrual Bleeding in Pediatric Patients Taking Anticoagulation

Catheter Directed Thrombolytic Therapy for Pediatric Cerebral Sinus Vein Thrombosis

Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database

Cerebral Venous Thrombosis Case Series at a Tertiary Care Hospital: Exploring Treatment Safety and Efficacy of Direct Oral Anticoagulants

A Pilot Study of an Oral Anticoagulant, Apixaban, in Secondary Prophylaxis of Venous Thromboembolism (VTE) in Children and Adolescents

Hydroxyurea Exposure throughout Pregnancy in Patients with Sickle-Cell Disease : 4 Case Reports from European Non-Interventional, Multicentric, Prospective Escort-HU Study

Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital

Who Are the Type 2 Von Willebrand Disease Patients? Results from Interim Analysis of the French HRQoL Study: Wish-Qol .

High Incidence and Recurrence Rate of Venous Thromboembolic Events in Patients with Sickle Cell Disease

Successful Management of Pregnancy with Severe Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor

Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay

Lipid-Mediated Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample

Post Transplant Prophylaxis with High Dose Valacyclovir through Day 100 Versus Day of Post Transplant Hospital Discharge Decreases Cytomegalovirus Reactivation in Adult Umbilical Cord Blood Transplant Recipients

Levels of Protein S and Risk of Thromboembolism

Validation of the Peds Clot Clinical Decision Rule [PCDR] in Hospital-Acquired Venous Thromboembolism

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Self-Reported Reproductive Health Experiences in Women with Von Willebrand Disease: A Qualitative Interview-Based Study

Epidemiology and Long-Term Outcomes of Estrogen/Progesterone Associated Distal Deep-Vein Thrombosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only